• Aucun résultat trouvé

RISK MANAGEMENT PLAN [BIMATOPROST/TIMOLOL] 0.3 MG/ML + 5 MG/ML, PRESERVATIVE FREE EYE DROPS, SOLUTION

N/A
N/A
Protected

Academic year: 2022

Partager "RISK MANAGEMENT PLAN [BIMATOPROST/TIMOLOL] 0.3 MG/ML + 5 MG/ML, PRESERVATIVE FREE EYE DROPS, SOLUTION"

Copied!
124
0
0

Texte intégral

Références

Documents relatifs

A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary

[r]

[LATANOPROST] 50 mcg/ml preservative free eye drops, solution is indicated for thereduction of elevated intraocular pressure in patients with open angle glaucoma and

SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN.. Keep out of the sight and reach

Profile comparison between Bimatoprost-Timolol 0.3mg/mL – 5mg/mL preservative free eye drops solution (Pharmathen) and Ganfort 0.3mg/mL – 5mg/mL eye drops solution in single

[r]

Bimatoprost-Timolol/Pharmathen 0.3mg/mL + 5mg/mL, Preservative Free, Eye drops solution, multidose container 2.3.A Appendices, p.1..

Bimatoprost-Timolol/Pharmathen 0.3mg/mL + 5mg/mL, Preservative Free, Eye drops solution, multidose container.. 2.4 Non-Clinical